TY  - GEN
AU  - Luzum,Jasmine A
AU  - Lanfear,David E
TI  - Pharmacogenetic Risk Scores for Perindopril Clinical and Cost Effectiveness in Stable Coronary Artery Disease: When Are We Ready to Implement?
SN  - 2047-9980
PY  - 2016///0824
KW  - Angiotensin-Converting Enzyme Inhibitors
KW  - therapeutic use
KW  - Coronary Artery Disease
KW  - drug therapy
KW  - Cost-Benefit Analysis
KW  - Humans
KW  - Perindopril
KW  - Pharmacogenetics
N1  - Publication Type: Editorial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Comment
UR  - https://doi.org/10.1161/JAHA.116.003440
ER  -